These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 3718377

  • 1. The effect of antimotion sickness drugs on habituation to motion.
    Wood CD, Manno JE, Manno BR, Odenheimer RC, Bairnsfather LE.
    Aviat Space Environ Med; 1986 Jun; 57(6):539-42. PubMed ID: 3718377
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms of antimotion sickness drugs.
    Wood CD, Manno JE, Wood MJ, Manno BR, Redetzki HM.
    Aviat Space Environ Med; 1987 Sep; 58(9 Pt 2):A262-5. PubMed ID: 3675502
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of antimotion sickness drug side effects on performance.
    Wood CD, Manno JE, Manno BR, Redetzki HM, Wood MJ, Mims ME.
    Aviat Space Environ Med; 1985 Apr; 56(4):310-6. PubMed ID: 3888169
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of efficacy of ginger with various antimotion sickness drugs.
    Wood CD, Manno JE, Wood MJ, Manno BR, Mims ME.
    Clin Res Pr Drug Regul Aff; 1988 Apr; 6(2):129-36. PubMed ID: 11538042
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Human assay of antimotion sickness drugs.
    Graybiel A, Wood CD, Knepton J, Hoche JP, Perkins GF.
    Aviat Space Environ Med; 1975 Sep; 46(9):1107-18. PubMed ID: 1100039
    [Abstract] [Full Text] [Related]

  • 8. Prevention of experimental motion sickness by scopolamine absorbed through the skin.
    Graybiel A, Knepton J, Shaw J.
    Aviat Space Environ Med; 1976 Oct; 47(10):1096-100. PubMed ID: 791234
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of anti-cholinergic and cholinergic drugs on habituation to motion in rats.
    Morita M, Takeda N, Hasegawa S, Yamatodani A, Wada H, Sakai S, Kubo T, Matsunaga T.
    Acta Otolaryngol; 1990 Oct; 110(3-4):196-202. PubMed ID: 2239207
    [Abstract] [Full Text] [Related]

  • 13. Motion sickness in cats: a symptom rating scale used in laboratory and flight tests.
    Suri KB, Crampton GH, Daunton NG.
    Aviat Space Environ Med; 1979 Jun; 50(6):614-8. PubMed ID: 475712
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of motion sickness in parabolic flight with buccal scopolamine.
    Norfleet WT, Degioanni JJ, Calkins DS, Reschke MF, Bungo MW, Kutyna FA, Homick JL.
    Aviat Space Environ Med; 1992 Jan; 63(1):46-51. PubMed ID: 1550533
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of transdermally administered scopolamine in preventing motion sickness.
    McCauley ME, Royal JW, Shaw JE, Schmitt LG.
    Aviat Space Environ Med; 1979 Nov; 50(11):1108-11. PubMed ID: 393242
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Side effects of some antimotion sickness drugs as measured by psychomotor test and questionnaires.
    Kennedy RE, Wood CD, Graybiel A, McDonough RB.
    Aerosp Med; 1966 Apr; 37(4):408-11. PubMed ID: 5954449
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.